Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04489173
Title TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer (TIBET)
Acronym TIBET
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Borstkanker Onderzoek Groep
Age Groups: adult | senior
Covered Countries NLD

No variant requirements are available.